Back to Search Start Over

Data from Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells

Authors :
Carl H. June
Michael C. Milone
Michael Kalos
Yangbing Zhao
Chrystal M. Paulos
F. Brad Johnson
Jesse M. Platt
Laurence J.N. Cooper
Sonny Ang
Avery D. Posey
Shannon E. McGettigan
Sonia Guedan
Omkar U. Kawalekar
John Scholler
Shinichiro Motohashi
Carmine Carpenito
Maria Ciocca Basil
Jihyun Lee
Matthew J. Frigault
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

This study compared second-generation chimeric antigen receptors (CAR) encoding signaling domains composed of CD28, ICOS, and 4-1BB (TNFRSF9). Here, we report that certain CARs endow T cells with the ability to undergo long-term autonomous proliferation. Transduction of primary human T cells with lentiviral vectors encoding some of the CARs resulted in sustained proliferation for up to 3 months following a single stimulation through the T-cell receptor (TCR). Sustained numeric expansion was independent of cognate antigen and did not require the addition of exogenous cytokines or feeder cells after a single stimulation of the TCR and CD28. Results from gene array and functional assays linked sustained cytokine secretion and expression of T-bet (TBX21), EOMES, and GATA-3 to the effect. Sustained expression of the endogenous IL2 locus has not been reported in primary T cells. Sustained proliferation was dependent on CAR structure and high expression, the latter of which was necessary but not sufficient. The mechanism involves constitutive signaling through NF-κB, AKT, ERK, and NFAT. The propagated CAR T cells retained a diverse TCR repertoire, and cellular transformation was not observed. The CARs with a constitutive growth phenotype displayed inferior antitumor effects and engraftment in vivo. Therefore, the design of CARs that have a nonconstitutive growth phenotype may be a strategy to improve efficacy and engraftment of CAR T cells. The identification of CARs that confer constitutive or nonconstitutive growth patterns may explain observations that CAR T cells have differential survival patterns in clinical trials. Cancer Immunol Res; 3(4); 356–67. ©2015 AACR.

Details

Database :
OpenAIRE
Accession number :
edsair.doi...........08f3bff5e6b4e8eccb2b0a30c2a678d8
Full Text :
https://doi.org/10.1158/2326-6066.c.6548833.v1